The release of tumor protein, translationally-controlled 1 (TPT1) by dying cancer cells has been shown to facilitate the recruitment of myeloid-derived suppressor cells (MDSCs) to the tumor microenvironment (TME), thereby promoting local immunosuppression and disease progression (30, 31). The gene discussed is TPT1; the disease is cancer.